Skip to content
Nonprofiteer
← FOGARTY INSTITUTE FOR INNOVATION

Form 990 for tax year 2023

Filed by FOGARTY INSTITUTE FOR INNOVATION.

Totals

Total revenue
$2,939,436
Total expenses
$7,630,781
Contributions and grants received
$178,952
Grants paid
$38,600
Program service revenue
$2,186,203
Investment income
$574,281
Other revenue
$0
Total assets, end of year
$21,350,391
Total liabilities, end of year
$11,020,749
Net assets or fund balances, end of year
$10,329,642
Program services expenses (Part IX)
$6,244,579
Management and general expenses
$1,230,756
Fundraising expenses
$155,446
Program service expenses (Part III)
$6,244,579

Program services were 81.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $178,952

  • 2a · Program service revenue: SPONSORED ACCESS FEE

    total $1,481,631 · related or exempt $1,481,631

  • 2b · Program service revenue: CIR ACCESS FEE

    total $690,320 · related or exempt $690,320

  • 2c · Program service revenue: REGISTRATION FEE

    total $14,252 · related or exempt $14,252

  • 3 · Investment income

    total $573,709 · excluded $573,709

  • 7a · Gross sales of assets other than inventory

    securities $572

  • 7b · Less cost or other basis and sales expenses

    securities $0

  • 7c · Gain or loss

    securities $572

  • 7d · Net gain or loss

    total $572 · excluded $572

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $38,600 · program services $38,600

  • 7 · Other salaries and wages

    total $4,154,217 · program services $3,236,321 · management and general $784,610 · fundraising $133,286

  • 9 · Other employee benefits

    total $671,210 · program services $537,685 · management and general $122,896 · fundraising $10,629

  • 10 · Payroll taxes

    total $250,976 · program services $193,456 · management and general $50,553 · fundraising $6,967

  • 11b · Fees: legal

    total $20,525 · program services $19,775 · management and general $750

  • 11c · Fees: accounting

    total $42,000 · management and general $42,000

  • 11g · Fees: other

    total $500,953 · program services $429,387 · management and general $71,456 · fundraising $110

  • 13 · Office expenses

    total $62,148 · program services $57,307 · management and general $4,829 · fundraising $12

  • 16 · Occupancy

    total $1,315,921 · program services $1,240,741 · management and general $71,756 · fundraising $3,424

  • 20 · Interest

    total $64,391 · program services $59,550 · management and general $4,654 · fundraising $187

  • 22 · Depreciation, depletion and amortization

    total $136,712 · program services $113,471 · management and general $23,241

  • 23 · Insurance

    total $34,515 · management and general $34,515

  • 24a · Other expenses: OTHER

    total $174,401 · program services $168,881 · management and general $5,384 · fundraising $136

  • 24b · Other expenses: DUES AND SUBSCRIPTIONS

    total $115,847 · program services $102,205 · management and general $13,000 · fundraising $642

  • 24c · Other expenses: EQUIPMENT RENTAL

    total $48,365 · program services $47,200 · management and general $1,112 · fundraising $53

Balance sheet

Part X, book values.

  • 2 · Savings and temporary cash investments

    beginning of year $7,627,533 · end of year $213,051

  • 3 · Pledges and grants receivable

    beginning of year $5,000,000 · end of year $5,000,000

  • 4 · Accounts receivable

    beginning of year $422,349 · end of year $464,679

  • 9 · Prepaid expenses and deferred charges

    beginning of year $172,498 · end of year $236,886

  • 10a · Land, buildings and equipment: cost or other basis

    $2,004,233

  • 10b · Land, buildings and equipment: accumulated depreciation

    $746,822

  • 10c · Land, buildings and equipment, net

    beginning of year $1,394,122 · end of year $1,257,411

  • 11 · Investments: publicly traded securities

    beginning of year $128,995 · end of year $2,864,006

  • 12 · Investments: other securities

    beginning of year $2,402,233 · end of year $2,664,198

  • 15 · Other assets

    beginning of year $9,793,178 · end of year $8,650,160

  • 17 · Accounts payable and accrued expenses

    beginning of year $41,025 · end of year $166,815

  • 19 · Deferred revenue

    beginning of year $145,743 · end of year $40,896

  • 23 · Secured mortgages and notes payable

    beginning of year $1,121,586 · end of year $1,165,603

  • 24 · Unsecured notes and loans payable

    beginning of year $1,283,659 · end of year $1,208,585

  • 25 · Other liabilities

    beginning of year $9,604,453 · end of year $8,438,850

  • 27 · Net assets without donor restrictions

    beginning of year $9,060,450 · end of year $4,694,978

  • 28 · Net assets with donor restrictions

    beginning of year $5,683,992 · end of year $5,634,664

Mission and programs · 2023

Mission

THE FOGARTY INSTITUTE FOR INNOVATION IS DEDICATED TO FINDING NEW WAYS TO TREAT ILLNESSES AND IMPROVE THE WELL-BEING OF PATIENTS THROUGH THE PRACTICAL APPLICATION OF INNOVATIVE IDEAS AND THE EDUCATION AND MENTORING OF MEDICAL INNOVATORS.

  • INNOVATION PROGRAM - FOR DECADES, THE UNITED STATES HAS BENEFITED FROM BEING HOME TO THE PRE-EMINENT MEDICAL INNOVATION ECOSYSTEM IN THE WORLD. THIS HAS ENSURED SUCCESS TO CUTTING-EDGE TREATMENT OPTIONS FOR THE NATION'S CITIZENS, HAS FUELED THE ECONOMY BY BEING A MAJOR DRIVER OF SMALL BUSINESS AND JOB CREATION, AND HAS REPRESENTED A SIGNIFICANT AND CRITICAL COMPONENT OF THE NATION'S OVERALL GLOBAL TECHNOLOGICAL LEADERSHIP. THE ULTIMATE GOAL OF THE 501(C)(3) NON-PROFIT FOGARTY INSTITUTE FOR INNOVATION IS TO SUPPORT MEDICAL INNOVATION TO BENEFIT PATIENTS. AS A NECESSARY CONSEQUENCE OF THIS EFFORT, THE INSTITUTE ADDRESSES THE FACTORS THREATENING THE NATION'S MEDICAL INNOVATION ECOSYSTEM HEAD-ON.THE UNIQUE APPROACH OF THE INSTITUTE IS TO IDENTIFY INNOVATIONS THAT HAVE ESPECIALLY HIGH POTENTIAL FOR PATIENT BENEFIT. THROUGH ITS FLAGSHIP INNOVATION SUPPORT PROGRAM, THE FOGARTY INSTITUTE RECEIVES APPLICATIONS FOR SUPPORT FROM A BROAD CANDIDATE POOL THAT INCLUDES PHYSICIANS, STUDENTS, ENGINEERS, AND ENTREPRENEURS. INNOVATIONS HAVING THE GREATEST POTENTIAL FOR PATIENT BENEFIT ARE SELECTED, AND THE INSTITUTE SUPPORTS THE INNOVATOR'S EFFORTS TO DELIVER THEIR INNOVATIONS TO PATIENTS. THE TYPES OF SUPPORT PROVIDED TO SELECTED INNOVATORS BY THE INSTITUTE INCLUDE (A) DIRECT MENTORING BY OTHER MEMBERS OF THE MENTOR STAFF IN THE PROCESS OF MEDICAL INNOVATION AND DEVELOPMENT, (B) SIGNIFICANT, ACCESS TO EL CAMINO HOSPITAL PHYSICIANS AND FACILITIES THAT PROVIDES INNOVATORS WITH INVALUABLE INFORMATION THAT GUIDES MEDICAL TECHNOLOGY DEVELOPMENT, (C) LABORATORY/ENGINEERING SPACE, (D) FINANCIAL AID, AND (E) ACCESS TO THE INSTITUTE'S NETWORK OF FUNCTIONAL EXPERTS.THE INSTITUTE'S LAB SPACE IS CURRENTLY DEVOTED TO THE DEVELOPMENT OF MEDICAL TECHNOLOGIES THAT ADDRESS A RANGE OF CONDITIONS, AND THESE INCLUDE NOT LIMITED TO MATERNAL AND INFANT HEALTH, CARDIOVASCULAR DISEASE, AND A VARIETY OF DIAGNOSTIC TOOLS.

    Expenses $4,290,051 · Grants $10,000 · Revenue $1,971,951

  • EDUCATION PROGRAM - THROUGH ITS EDUCATION PROGRAM, THE FOGARTY INSTITUTE MAKES ITS UNIQUE MENTORING CAPABILITY AVAILABLE TO A MUCH LARGER AUDIENCE THAN IS POSSIBLE WITH THE INNOVATION SUPPORT PROGRAM BY PROVIDING WORKSHOPS, SEMINARS AND INTERNSHIPS TO INTERESTED MEMBERS OF THE MEDICAL INNOVATION, CLINICIAN, AND ENTREPRENEUR COMMUNITIES. IN THIS WAY, WE HOPE TO NOT ONLY SUPPORT ACTIVE INNOVATORS, BUT ALSO INSPIRE THE NEXT GENERATION OF MEDICAL INNOVATORS SUCH AS COLLEGE AND HIGH SCHOOL STUDENTS WHO MAY BE CONSIDERING A CAREER IN MEDICAL INNOVATION.

    Expenses $1,954,528 · Grants $28,600 · Revenue $214,252

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Thomas Fogarty MD

    FOUNDER/DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Thomas M Krummel MD

    CHAIRMAN

    Total calculated
    $0
    Hours/week
    2
  • Frederick St Goar MD

    VICE CHAIRMAN

    Total calculated
    $0
    Hours/week
    2
  • J Casey McGlynn JD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Lewis Wexler MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Allan R Will

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Andrew Cleeland

    CEO

    Total calculated
    $331,306
    From this org
    $290,372
    From related orgs
    $0
    Other
    $40,934
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $290,372
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $40,934
    Filer's total
    $331,306
  • Stacy Enxing-Seng

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Angela MacFarlane

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Mark Leahey

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Gayle Kuokka

    CFO

    Total calculated
    $352,840
    From this org
    $309,547
    From related orgs
    $0
    Other
    $43,293
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $309,547
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $43,293
    Filer's total
    $352,840
  • Marga Ortigas-Wedekind

    CHIEF STRATEGY OFFICER

    Total calculated
    $370,268
    From this org
    $330,057
    From related orgs
    $0
    Other
    $40,211
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $330,057
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $40,211
    Filer's total
    $370,268
  • Denise Zarins

    CHIEF OPERATING OFFICER

    Total calculated
    $333,184
    From this org
    $305,250
    From related orgs
    $0
    Other
    $27,934
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $305,250
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $27,934
    Filer's total
    $333,184
  • Michael Regan

    CHIEF OPERATING OFFICER

    Total calculated
    $350,590
    From this org
    $328,493
    From related orgs
    $0
    Other
    $22,097
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $328,493
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $22,097
    Filer's total
    $350,590
  • Allie Gregorian

    CHIEF ALLIANCE OFFICER

    Total calculated
    $260,886
    From this org
    $259,625
    From related orgs
    $0
    Other
    $1,261
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $259,625
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $1,261
    Filer's total
    $260,886
  • John Morriss

    DIRECTOR OF INVENTION

    Total calculated
    $299,083
    From this org
    $284,650
    From related orgs
    $0
    Other
    $14,433
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $284,650
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $14,433
    Filer's total
    $299,083

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • FOGARTY CLINICAL RESEARCH INC

    C · CLINICAL RESEARCH · CA · 100% owned · share of income -$1,162 · share of assets $48,953 · controlled entity

    Directly controlled by FOGARTY INSTITUTE FOR INNOVATION

  • CHARITABLE REMAINDER TRUSTS

    T · TRUST · CA · 100% owned

    Directly controlled by FOGARTY INSTITUTE FOR INNOVATION

Provenance

Return type
form_990
Tax year
2023
Filed
14 November 2024
IRS schema version
2023v5.1
Source object
202443199349318914

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.